F6H8 as an Intraoperative Tool and F6H8/Silicone Oil as a Postoperative Tamponade in Inferior Retinal Detachment with Inferior PVR

Table 1

Clinical data of patients with inferior retinal detachment and inferior PVR.

Patient

age/sex

Visual acuity at entrance examination

Diagnosis

Associated ocular abnormalities

Previous retinal surgery

Lens status

Surgery with fluoron tamponade

F6H8/SO ratio

Problems with fluoron

Procedure after fluoron use

Fluoron removal (time between use and removal); (months)

Complications

Actual status; (VA, retina status)

Followup; (months)

1

80/F

CF

RD, PVR

Retinoschisis

None

P

SB-PE-IOLI-Vx-F

70/30

TCT, PS

FR

4

None

CF, A

40

2

34/M

CF

RD, PVR

HM

SB

PP

Vx-F

70/30

TCT

FR

3

Inflammatory reaction 1 y after FR

LP, D

36

3

67/M

CF

RD, PVR

CED

Vx-SO; Vx-SO

AP

SB-Vx-F; Vx-R-F

70/30; 60/40

TCT, PVR

SF-FR

2, 3

None

20/100, A

32

4

68/M

CF

RD, PVR

GL

PE-IOLI-Vx-SO; SB-Vx-SO

PP

Vx-R-F

60/40

TCT

FR

3

None

20/100, A

48

5

67/F

LP

RD, PVR

GL, CED

SB-Vx-SO

PP

Vx-F

60/40

TCT

FR

3

None

CF, A

36

6

80/M

CF

RD, PVR

HM

SB-Vx-G

PP

Vx-F

60/40

TCT, H

FR-SO

3

H

20/200, A, SO not removed

28

7

74/F

MM

RD, PVR

GL

SB

PP

Vx-R-F

60/40

TCT

FR-MP-G

3

None

20/200, A

28

8

78/F

LP

RD, PVR

H

SB-Vx-SO

PP

Vx-F

60/40

TCT, PS, H

FR-SO

4

H

20/200, H, A, SO not removed

36

9

54/M

MM

RD, PVR

GL, HM

T; PE-IOLI-Vx-G

PP

Vx-F; Vx-F

60/40;   50/50

PS, H, TCT, PVR

FR-G

3, 4

H (4 month duration)

20/200, A

18

10

58/M

CF

RD, PVR

None

SB-Vx-SO

PP

Vx-F

50/50

H

FR

3

None

20/100, H, A

16

11

80/F

CF

RD, PVR

HM

None

PP

SB-Vx-MP-F

50/50

F in anterior chamber

FR

3

None

20/200, A

12

12

58/M

CF

RD, PVR

None

SB-Vx-SO

PP

Vx-F

40/60

None

FR

3

None

20/200, A

16

13

70/M

LP

RD, PVR

None

None

PP

SB-Vx-F

40/60

Inferior retinal hemorrhages

FR

5

None

20/100, A

12

14

78/F

CF

RD, PVR

None

SB-Vx-SO

PP

Vx-F

30/70

Superior PVR

FR-R-SO; SOR

3

None

20/100, A

12

15

81/M

20/400

RD, PVR

None

None

PP

SB-Vx-F

30/70

None

FR

3

None

20/70, A

12

16

79/F

LP

RD, PVR

None

None

PP

SB-Vx-F

30/70

Macular PVR, PS

None

—

None

CF, A, F not removed

14

17

84/M

CF

RD, PVR

FB

None

P

PE-SB-Vx-R-F-FBR

30/70

Superior PVR, H

FR, Vx-MP-SO;

1

H

CF, H, A, SO not removed

12

18

76/F

20/400

RD, PVR

None

None

PP

SB-Vx-F

30/70

None

FR

5

CME

20/100, A

12

19

55/F

MM

RD, PVR

None

None

PP

SB-Vx-F

30/70

CME

FR

3

CME (3-month duration)

20/80, A

12

20

80/M

CF

RD, PVR

None

None

PP

SB-Vx-F

30/70

None

FR

3

None

20/100, A

42

21

74/M

CF

RD, PVR

None

None

P

SB-PE-Vx-F

30/70

PS

FR

3

None

20/100, A

12

22

56/F

CF

RD, PVR

HM

PE-IOLI-SB-Vx-G; Vx-SO

PP

Vx-MP-F

30/70

Superior PVR

FR-Vx-MP-SO; SOR

3

None

20/400, A

12

A: attached; AP: aphakia; CED: corneal endothelial dystrophy; CF: count fingers; CME: cystoid macular edema; D: detached; F: F6H8; FB: foreign body; FBR: foreign body removal; FR: F6H8 removal; G: gas; GL: glaucoma; H: hypotony; M: high myopia; IOLI: intraocular lens implantation; LP: light perception; HM: hand motions; MP: membrane peeling; P: phakia; PE: phacoemulsification; PP: pseudophakia; PS: posterior synechiae; PVR: proliferative vitreoretinopathy; R: retinotomy; RD: retinal detachment; SB: scleral buckle; SF: scleral fixation; SO: silicone oil; SOR: silicone oil removal; T: trabeculectomy; TCT: temporary cloudiness of the tamponade; Vx: vitrectomy.